Literature DB >> 7882988

T-cell antigen receptor-induced signal-transduction pathways--activation and function of protein kinases C in T lymphocytes.

M Szamel1, K Resch.   

Abstract

CONTENTS. T-cell activation--Structure of the T-cell antigen receptor--Modular organisation of the T-cell antigen receptor--T-cell antigen receptor-coupled signaling pathways: Activation of protein-tyrosine kinase by the T-cell antigen receptor; Signal transduction in lymphoid cells involves several protein-tyrosine kinases in parallel; Regulation of T-cell antigen receptor signaling by the phosphoprotein phosphatase CD45--Consequences of T-cell antigen receptor-induced tyrosine phosphorylation: Activation of phosphoinositol-lipid-turnover pathways--Activation of phospholipase C-gamma-1: p59fyn or p56lck?--G-protein motif of CD3-gamma: relevance for signal transduction--Association of lipid kinase with the T-cell antigen receptor--Intracellular signaling by phospholipid metabolites and calcium: activation of protein kinase C--Protein kinase C isoenzymes--Heterogenity of protein kinase C and mode of activation--Phospholipid-derived mediators in activation of protein kinase C in T-cells--Role of phospholipase D metabolites in activation of protein kinase C--Polyunsaturated fatty acids and lysophosphatidylcholine as activators of protein kinase C--Potein kinase C and p21ras function in interdependent and distinct signaling pathways during T-cell activation--Raf-1 kinase: regulator or target of protein kinase C?--Summary and perspectives.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882988     DOI: 10.1111/j.1432-1033.1995.tb20221.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

1.  The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.

Authors:  T Schnaider; J Somogyi; P Csermely; M Szamel
Journal:  Cell Stress Chaperones       Date:  2000-01       Impact factor: 3.667

2.  A new approach for quantitative phosphoproteomic dissection of signaling pathways applied to T cell receptor activation.

Authors:  Vinh Nguyen; Lulu Cao; Jonathan T Lin; Norris Hung; Anna Ritz; Kebing Yu; Radu Jianu; Samuel P Ulin; Benjamin J Raphael; David H Laidlaw; Laurent Brossay; Arthur R Salomon
Journal:  Mol Cell Proteomics       Date:  2009-07-14       Impact factor: 5.911

3.  Functional expression of the P2Y14 receptor in murine T-lymphocytes.

Authors:  Michelle Scrivens; John M Dickenson
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 4.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

5.  Inhibition by fenamates of calcium influx and proliferation of human lymphocytes.

Authors:  H Kankaanranta; M Luomala; O Kosonen; E Moilanen
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

6.  Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.

Authors:  E Bianchi; E Ferrero; F Fazioli; F Mangili; J Wang; J R Bender; F Blasi; R Pardi
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

7.  The changes of protein kinase C activity in peripheral blood lymphocytes in the patients with obstructive jaundice and the implication.

Authors:  J Wang; Q Zou; S Zou
Journal:  J Tongji Med Univ       Date:  2001

8.  Linkage of protein kinase C-beta activation and intracellular interleukin-2 accumulation in human naive CD4 T cells.

Authors:  J Hassan; E Rainsford; D J Reen
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

9.  In vivo and in vitro phosphorylation of annexin II in T cells: potential regulation by annexin V.

Authors:  T Dubois; J P Oudinet; F Russo-Marie; B Rothhut
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors.

Authors:  J Van Wauwe; F Aerts; H Walter; M de Boer
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.